Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards

BACKGROUND AND INTRODUCTION: Growing evidence supports a combined modality treatment strategy for patients with oligometastatic disease. However, lack of phase III trial data and uncertainties around patient selection highlight the importance of multidisciplinary tumor boards (MDT) in therapeutic de...

Descripción completa

Detalles Bibliográficos
Autores principales: Christ, Sebastian M., Heesen, Philip, Muehlematter, Urs J., Pohl, Kaspar, William Thiel, Gabriel, Willmann, Jonas, Ahmadsei, Maiwand, Kroese, Tiuri E., Mayinger, Michael, Balermpas, Panagiotis, Wicki, Andreas, Andratschke, Nicolaus, Huellner, Martin, Guckenberger, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676209/
https://www.ncbi.nlm.nih.gov/pubmed/36420098
http://dx.doi.org/10.1016/j.ctro.2022.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676209/
https://www.ncbi.nlm.nih.gov/pubmed/36420098
http://dx.doi.org/10.1016/j.ctro.2022.11.008

Ejemplares similares